biOasis

91 articles about biOasis

• biOasis Announces Voting Results For 2017 Annual Meeting

  9/22/2017

• biOasis Announces Rob Hutchison, Founder, To Retire As Chairman & Board Member

  9/19/2017

• biOasis Announces Formation Of Scientific Advisory Board To Advance The Science For The Company’s Blood-Brain Barrier Drug Delivery Platform

  9/7/2017

• biOasis Enters Into A License Agreement With Vaccinex, Inc.

  9/23/2016

• biOasis To Present At The 1st Annual Neuroscience BioPartnering And Investment Forum In New York On February 23, 2016

  2/12/2016

• biOasis' BT2111-Herceptin(R) Program Achieves Significant Positive Results From Antibody Dependent Cell-Mediated Cytotoxicity Assay

  3/13/2012

• biOasis Announces Transcend Vector Results With a Therapeutic Antibody That Targets Metastatic Breast Cancer

  7/6/2011

• biOasis Director Resigns

  6/24/2011

• biOasis to Present on Drug Delivery at International Conference on Cerebral Vascular Biology

  6/22/2011

• biOasis Initiates Transcend Vector Program Targeting Treatments for CNS Symptoms of Lysosomal Storage Disorders

  5/11/2011

• biOasis Receives Verification That Transcend Localizes to a Number of Cell Types in the Brain

  5/2/2011

• biOasis Adds MarketSmart Communications Inc. to Investor Relations Team

  4/18/2011

• biOasis Receives Significant Independent Results From Its Transcend Program

  4/14/2011

• biOasis Director Resigns

  4/14/2011

• biOasis Poster Being Presented at 17th Annual Blood-Brain Barrier Consortium Meeting

  3/24/2011

• biOasis Release: Cognitest(TM) - Diagnostic Blood Test for Alzheimer's Disease - Milestone Attained

  2/28/2011

• biOasis Enters Agreement With National Research Council of Canada

  11/29/2010

• biOasis Receives Blood-Brain Barrier Research Report From the University of British Columbia

  10/19/2010

• biOasis Presents Research Results on Transcend(TM) at International Symposium on the Blood-Brain Barrier

  9/7/2010

• Former BioMarin Pharmaceutical Inc. and AngioChem Executive Joins the biOasis Scientific Advisory Board

  5/27/2010